RT Journal Article
SR Electronic
T1 Pulmonary Embolism Obstruction Model to Evaluate Clinical Deterioration
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.27.23293295
DO 10.1101/2023.07.27.23293295
A1 Yeh, Jian-Kuan
A1 Chen, Po-Wei
A1 Chang, Wei-Ting
A1 Chiu, Pin-Hsuan
A1 Su, Pei-Fang
A1 Hsu, Chih-Hsin
A1 Lin, Chih-Chan
A1 Chang, Hsien-Yuan
YR 2023
UL http://medrxiv.org/content/early/2023/08/02/2023.07.27.23293295.abstract
AB Hemodynamic instability may develop in patients with acute pulmonary embolism (PE) days after the emboli event. Simplified methods to predict clinical deterioration are currently lacking. This retrospective cohort study included patients diagnosed with acute. The aim is to develop a simplified imaging model with good clinical accessibility to predict the clinical deterioration of patients with acute PE. This study included patients with acute PE under the International Classification of Disease, ninth or tenth revision. Seven models based on computed tomography pulmonary angiography (CTPA) were developed based on the location (central versus peripheral) and the degree (nearly total versus partial) of obstruction. The outcome includes clinical deterioration, which is defined as death from PE, cardiopulmonary resuscitation, mechanical ventilation, vasopressor therapy, thrombolysis, catheter-directed therapy, and surgical embolectomy. Logistic regression analysis was used to test the association between different models and clinical deterioration. The area under the receiver operating characteristic curve (AUC) was used to test the predictive ability. The category-free net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were used to quantify the improvement of the proposed models plus the simplified Pulmonary Severity Index (sPESI) compared with the sPESI alone. Calculating the nearly totally obstructed 20 peripheral arteries provides good predictive ability in the seven models (AUC: 0.77). Calculating nearly totally obstructed 20 peripheral segments can predict clinical deterioration. Obstruction on CTPA combined with the sPESI increased the ability to predict clinical deterioration compared to the sPESI alone and may be used as guidance in clinical decision-making.Clinical perspective A simple model based on computed tomography pulmonary angiography (CTPA) to predict clinical deterioration in patients with acute pulmonary embolism (PE) is currently lacking.This retrospective study included 210 patients and used the model for calculating the nearly totally obstructed segmental pulmonary arteries as an efficient and simple method to predict clinical deterioration. This model added to the simplified PE severity index (sPESI) has an increased predictive ability compared to the sPESI alone. CTPA images can predict the clinical deterioration of patients with acute PE and may assist in clinical decision-making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the grants from National Cheng Kung University Hospital, Tainan, Taiwan (NCKUH-11003021) and by the grants from An Nan Hospital, China Medical University, Tainan, Taiwan (ANHRF112-29).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Research and Ethics Committee of the National Cheng Kung University Hospital (IRB number: B-ER-109-102) Human Research and Ethics Committee of the Chi Mei Medical Center (IRB number: CMMC11011-002)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableThe data that support the findings of this study are available from the corresponding author upon reasonable request.